RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer
Clinical trial NCT05996952 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05996952
- Sponsor
- West China Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-08-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.